… immunotherapy, especially for the aggressive variants. Tumour initiation and progression
in thyroid cancer … and progression of thyroid cancer and implications for immunotherapy. …

… Early data are now accumulating in progressive thyroid cancers … thyroid cancers, the latest
and ongoing immune-based approaches, and the future of immunotherapies in thyroid cancer…

… clinically aggressive thyroid cancers, we aimed to investigate whether there is a difference
in immunosuppressive markers expression, including potential immunotherapeutic targets …

… While these drugs remain reserved for thyroid cancer patients who failed all treatment …
thyroid cancers, radioactive iodine (RAI) resensitization and finally a section on immunotherapy…

… Many studies have shown that thyroid cancer (TC) cells produce … immunotherapy in thyroid
cancer. More recently a case has been described involving anaplastic thyroid cancer treated …

… The new immunotherapy targeting the programmed cell death 1 (PD-1) receptor and its
cognate ligand PD-L1 has renewed hopes of eradicating the most difficult human …

… of patients with papillary thyroid cancer (PTC) have a … cancers, we aimed to investigate the
immune landscape in PTC and its potential implications for prognosis and immunotherapy. In …

… thyroid cancer and for those with thyroid cancer refractory to standard treatments. Immunotherapy
is … for patients with unresectable or metastatic cancers nowadays. Antibodies targeting …

… needed for aggressive thyroid cancers, including immunotherapy. … immunotherapeutic
implications in PTC were analyzed by means of mRNA transcriptome data obtained in The Cancer …

… The thyroid cancer microenvironment is rich in immunological cells, making it a reasonable
… for immunotherapy. This review maps out the immunological features of thyroid cancers and …